FAM83A drives PD-L1 expression via ERK signaling and FAM83A/PD-L1 co-expression correlates with poor prognosis in lung adenocarcinoma

Fengrui Zhou; Xin Wang; Fang Liu; Qingwei Meng; Yan Yu

doi:10.1007/s10147-020-01696-9

ScienceGate Book Chapters

JOURNAL ARTICLE

FAM83A drives PD-L1 expression via ERK signaling and FAM83A/PD-L1 co-expression correlates with poor prognosis in lung adenocarcinoma

Fengrui Zhou Xin Wang Fang Liu Qingwei Meng Yan Yu

Year: 2020 Journal: International Journal of Clinical Oncology Vol: 25 (9)Pages: 1612-1623 Publisher: Springer Science+Business Media

DOI: 10.1007/s10147-020-01696-9

Get Full-Text PDF Get Analytical Report

Keywords:

Immunohistochemistry Adenocarcinoma Western blot MAPK/ERK pathway Cancer research Downregulation and upregulation Signal transduction Medicine Biology Cancer Pathology Internal medicine Gene Cell biology

Metrics

Cited By

3.72

FWCI (Field Weighted Citation Impact)

Refs

0.93

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Peptidase Inhibition and Analysis

Health Sciences → Medicine → Oncology

Cancer Immunotherapy and Biomarkers

Health Sciences → Medicine → Oncology

Cancer Mechanisms and Therapy

Health Sciences → Medicine → Pathology and Forensic Medicine

FAM83A drives PD-L1 expression via ERK signaling and FAM83A/PD-L1 co-expression correlates with poor prognosis in lung adenocarcinoma

Metrics

Citation History

Topics

Related Documents

Tumor necrosis correlates with PD-L1 and PD-1 expression in lung adenocarcinoma

Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma

UBE2V2 Positively Correlates With PD-L1 Expression and Confers Poor Patient Survival in Lung Adenocarcinoma

P1.09-24 Tumor Necrosis Correlates with PD-L1 and PD-1 Expression in Lung Adenocarcinoma

CMTM6, the newly identified PD-L1 regulator, correlates with PD-L1 expression in lung cancers